Application

PTO- 1478

Approved for use through 02/28/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 02/28/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90517791

Filing Date: 02/08/2021

To the Commissioner for Trademarks:

MARK: MEDICATION INTELLIGENCE (Standard Characters, see mark)
The literal element of the mark consists of MEDICATION INTELLIGENCE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Kit Check, Inc., a corporation of District of Columbia, having an address of
      1800 Duke St Ste 108
      Alexandria, Virginia 22134
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 006:  Metal boxes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 009:  RFID scanning readers for tracking and taking inventory of pharmaceuticals and medical supplies
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 012:  Carts; Mobile storage carts for commercial use; Mobile storage carts for dispensing pharmaceuticals and medical supplies
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Providing temporary use of non-downloadable computer software for tracking and taking inventory of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for auditing medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for reporting data in medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Providing temporary use of non-downloadable computer software for tracking pharmaceuticals and medical supplies including collecting, organizing, disseminating, creating analytic and statistic models, and reporting data regarding the manufacture, inspection, regulatory compliance, supply, distribution, attributes, and sale of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for tracking pharmaceuticals and medical supplies including collecting, organizing, disseminating, creating analytic and statistic models, and reporting data regarding the persons, entities, systems and machines that have participated in the manufacture, inspection, regulatory compliance, supply, distribution, attributes, and sale of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for dispensing pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for administering pharmaceuticals; Providing temporary use of non-downloadable computer software for supply chain management systems for pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for inventory management systems for pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for collecting, organizing, disseminating, creating analytic and statistic models, and reporting data contained in electronic medical records, pharmaceutical purchasing systems, supply chain management systems, inventory management systems, pharmaceutical manufacturing systems, pharmaceutical regulatory systems, and pharmaceutical compliance and surveillance systems; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for tracking and taking inventory of pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for auditing medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Software as a service (SAAS) services featuring software for tracking pharmaceuticals and medical supplies including collecting, organizing, disseminating, creating analytic and statistic models, and reporting data regarding the manufacture, inspection, regulatory compliance, supply, distribution, attributes, and sale of pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for tracking pharmaceuticals and medical supplies including collecting, organizing, disseminating, creating analytic and statistic models, and reporting data regarding the persons, entities, systems and machines that have participated in the manufacture, inspection, regulatory compliance, supply, distribution, attributes, and sale of pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for dispensing pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for administering pharmaceuticals; Software as a service (SAAS) services featuring software for supply chain management systems for pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for inventory management systems for pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for collecting, organizing, disseminating, creating analytic and statistic models, and reporting data contained in electronic medical records, pharmaceutical purchasing systems, supply chain management systems, inventory management systems, pharmaceutical manufacturing systems, pharmaceutical regulatory systems, and pharmaceutical compliance and surveillance systems; Software as a service (SAAS) services featuring software for implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards for tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with tracking, auditing, assessing, reviewing, and reporting data found in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with tracking and taking inventory of pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with auditing medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Developing quality control, usage, compatibility, and interoperability standards in connection with supply chain management systems for pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with inventory management systems for pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with supply chain management systems for pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with inventory management systems for pharmaceuticals and medical supplies; Testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; Providing authentication and verification services using computer hardware and software for pharmaceuticals, medical dispensing systems, and medical supplies; Developing and maintaining a registry of approved identification numbers for use with an authentication and verification service for pharmaceuticals, medication dispensing systems, and medical supplies; Developing and maintaining a registry of data regarding the manufacture, inspection, regulatory compliance, supply, distribution, attributes, and sale of pharmaceuticals and medical supplies; Creating and assigning identification numbers and radio frequency identification (RFID) tags for use with an authentication and verification service for pharmaceuticals, medication dispensing systems, and medical supplies; Data warehousing
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Gregory B. Phillips. Other appointed attorneys are John B. Sganga, Jr., Edward A. Schlatter, Gerard von Hoffmann, Joseph R. Re, Catherine J. Holland, John M. Carson, Jeffrey L. Van Hoosear, Daniel E. Altman, Lynda J. Zadra-Symes, William H. Shreve, Stephen C. Jensen, Steven J. Nataupsky, Paul A. Stewart, Joseph F. Jennings, Craig S. Summers, Diane M. Reed, Ronald J. Schoenbaum, John R. King, Adeel S. Akhtar, David N. Weiss, Douglas G. Muehlhauser, Lori Lee Yamato, Michael K. Friedland, Stacey R. Halpern, Jon W. Gurka, Joseph M. Reisman, Michael L. Fuller, Paul N. Conover, Robert J. Roby, Sabing H. Lee, Karoline A. Delaney, Joseph S. Cianfrani, William R. Zimmerman, Eric S. Furman, Susan M. Natland, Rose M. Thiessen, Michael A. Guiliana, Rabinder N. Narula, Bruce S. Itchkawitz, John M. Grover, Irfan A. Lateef, Amy Christensen Chun, Mark J. Gallagher, David G. Jankowski, Brian C. Horne, Payson LeMeilleur, Sheila N. Swaroop, Benjamin A. Katzenellenbogen, Andrew N. Merickel, Thomas P. Krzeminski, Linda H. Liu, James F. Herkenhoff, Andrew M. Douglas, Salima A. Merani, Jonathan A. Hyman, Curtiss C. Dosier, Joseph J. Mallon, Sean M. Murray, Christy G. Lea, Perry D. Oldham, Russell M. Jeide, Zi Y. Wong, Matthew S. Bellinger, Gregory A. Hermanson, Lauren Keller Katzenellenbogen, Ted M. Cannon, Carol Pitzel Cruz, Josué A. Villalta, Andrew I. Kimmel, Brenden Gingrich, Maria Culic Anderson, Melanie J. Seelig, Mauricio A. Uribe, Curtis R. Huffmire, Christopher L. Ross, Eli A. Loots, Ryan E. Melnick, Yanna S. Bouris, Philip M. Nelson, Marko R. Zoretic, Kerry S. Taylor, Derek C. Dailey, Jarom D. Kesler, Colin B. Heideman, Theodore G. Papagiannis, Nicholas M. Zovko, Adam J. Gilbert, Kimberly J. Miller, Bryan W. Wahl, Thomas Y. Yee, Agnes Juang, Jason J. Jardine, Jared C. Bunker, Lance D. Smemoe, Joshua J. Stowell, Jonathan E. Bachand, Ali S. Razai, Terry K. Tullis, Derek R. Bayles, Cheryl T. Burgess, Gregory B. Phillips, Brian C. Claassen, Mark Lezama, Sean Ambrosius, Stephen W. Larson, John L. Paik, Michael R. Christensen, Benjamin J. Everton, Jason A. Gersting, Baraa Kahf, Alan G. Laquer, Vlad Teplitskiy, Jeffery L. Hallstrom, Maria V. Stout, William O. Adams, Ian W. Gillies, Andrew W. Lloyd, Mark D. Kachner, Lincoln S. Essig, David R. Trossen, Aaron M. Davis, Jason R. Swartz, Benjamin B. Anger, Jason A. Champion, Daniel V. Gibson, Jeremy J. Carney, Karen M. Cassidy, Adam B. Powell, Karen J. Lenker, Bryan G. McWhorter, Nathanael R. Luman, Andrea L. Cheek, Damien J. Howard, Jane Q. Dai, Shannon Lam, Peter Law, Mark Metzke, Jacob Peterson, Christie R.W. Matthaei, Vladimir S. Lozan, Paul S. Stellman, Heungsoo Choi, Nicole Rossi Townes, Vikas Bhargava, Jeremy A. Anapol, Scott A. Cromar, Kendall M. Loebbaka, David R. Schmidt, Harnik Shukla, Charlene A. Azema, Morgan R. Coates, Jessica L. Achtsam, Jonathan A. Menkes, Rosaleen H. Chou, Deborah S. Shepherd, Mark D. Marsden, Joan Y. Chan, Kyu S. Min, Chang Sik Lim, Thomas S.H. Cowan, Devanie A. DuFour, Alexander J. Martinez, Hans L. Mayer, Jessica C. Sganga, Nicholas A. Belair, Ryan S. Furtado, Angela K. Dremann, Justin J. Gillett, M. Scott Forbes, Brian M. Graham, Brian J. Flynn, Mitchell B. Hadley, Elenore Niu, David M. Cohen, Mark E. Davis, Jordan Gottdank, Kim A. Kennedy, Daniel C. Kiang, Keith M. Lim, Ashley C. Morales, Nathan D. Reeves, Brandon G. Smith, Xiaoyan Sabrina Wang, Jun Hyuk (Zach) Hong, Jordan M. Cox, Albert J. Sueiras, Mark Rubinshtein, David J. Grant, Clayton R. Henson, Daniel A. Kamkar, Lesley Y. Kim, Josepher Li, Jacob R. Rosenbaum, Douglas B. Wentzel, Aryeh N. Feinstein, Noorean I. Gill, Aaron S. Johnson, Bryan J. Johnson, Chanell Khosrowabadi, Lindsay A. Laddaran, Janet M. Allendorph, Alexander Zeng, Sean S. Kim, Adam R. Aquino, Samuel I. Cockriel, Serah R. Friedman, Bita Kianian, Eric R. Malmgren, Brian M.Z. Reece, Suyoung Jang, Show Xiaoyu Wang, Justin E. Culbertson, Andrew E. Morrell, Victoria E. Ellis, Yasmin L. Amin-Reimer, Catherine R. Gourash, Marissa M. Rosenbaum, Brok S. Humbert, Karl W. Kowallis, Christopher L. Lewis, Ryan L. McBride, Atiya M. Myers, David C. O'Hair, Radhika K. Raman, Ben K. Shiroma, Makoto Tsunozaki, Benjamin L. Van Adrichem, James Yang, Tiffany T. Young, Matthew S. Friedrichs, Payne McQueen Montgomery, David G. Kim, Jeremiah S. Helm, Hironori Kubota, Kregg A. Koch, James E. Youngblood, Yusuke Hirai, Sunyong Tang, and Hyeon S. Kim. Gregory B. Phillips of Knobbe Martens Olson & Bear, LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      2040 Main Street, 14th Floor
      Irvine, California 92614
      United States
      949-760-0404(phone)
      949-760-9502(fax)
      efiling@knobbe.com
The docket/reference number is KIT.038T.
Gregory B. Phillips submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Gregory B. Phillips

PRIMARY EMAIL FOR CORRESPONDENCE: efiling@knobbe.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $1400 has been submitted with the application, representing payment for 4 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Timothy Kress-Spatz/   Date: 02/08/2021
Signatory's Name: Timothy Kress-Spatz
Signatory's Position: Co-Founder
Signatory's Phone Number: 949-760-0404
Signature method: Sent to third party for signature
Payment Sale Number: 90517791
Payment Accounting Date: 02/08/2021

Serial Number: 90517791
Internet Transmission Date: Mon Feb 08 12:20:46 ET 2021
TEAS Stamp: USPTO/BAS-XXX.XXX.XX.XX-2021020812204655
9442-90517791-7608acc6247a9a9bb1396bb32c
c448f54771a68b3d8132ccdcedb473b1d77fb-CC
-20452483-20210129170027903263